Proceeds from the contemporary problem will likely be used to repay debt, fund the working-capital necessities of the corporate, and pursue inorganic development initiatives by way of acquisition and for common company functions.
Akums is a pharmaceutical contract improvement and manufacturing organisation providing a complete vary of pharmaceutical services in India and abroad. In June, the prescribed drugs firm launched a mix drug for gastrointestinal tract issues.
ICICI Securities Ltd, Axis Capital Ltd., Citigroup International Markets India Pvt. and Ambit Pvt. are the book-running lead managers for the problem. The shares will likely be listed on the Nationwide Inventory Alternate and on the BSE.
%2018_04_2024..jpg?rect=0%2C30%2C1600%2C840&w=1200&auto=format%2Ccompress&ogImage=true "Goldman Sachs Purchase 4% Stake For Rs 2,103.74 Crore")
